跳至主要内容
临床试验/NCT01728610
NCT01728610已完成2 期

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms (IBS-2)

Danisco4 个研究点 分布在 1 个国家目标入组 391 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
391
试验地点
4
主要终点
Change in functional bowel symptoms

研究概览

简要总结

The purpose of this study is to analyse the effect of a probiotic supplement on functional intestinal symptoms among subjects diagnosed with irritable bowel syndrome (IBS).

详细描述

The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on functional intestinal symptoms among subjects diagnosed with IBS according to Rome III criteria. Subjective assessment of bowel symptoms, quality of life, anxiety and depression and adequate relief will be assessed as with questionnaires as outcome measures. The intestinal microbiota will be analysed from faecal samples.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects aged 18 to 65 fulfilling Rome III criteria for IBS will be recruited. Sufficient general health and orientation for participating in the study is required and will be evaluated by the MDs.

排除标准

  • Diagnosed or suspected organic gastrointestinal diseases or severely impaired general health.

结局指标

主要结局

Change in functional bowel symptoms

时间窗: 0 weeks, 4 weeks, 12 weeks

Validated questionnaire

次要结局

  • Change in faecal microbiota(0 weeks, 4 weeks, 12 weeks)
  • Change in anxiety and depression(0 weeks, 4 weeks and 12 weeks)
  • Change in quality of life(0 weeks, 4 weeks, 12 weeks)
  • Adequate relief(Weekly over 3 month intervention)
  • Safety of investigational product(Throughout the intervention phase)

研究者

发起方
Danisco
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验